MVC-COV1901

· Medigen Vaccine Biologics Corp.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for MVC-COV1901, covering 2021-12-23 to 2024-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults [Phase 4]

See pricing